Pro Medicus (Australia) Performance
| PME Stock | 125.96 8.99 7.69% |
The company holds a Beta of 0.86, which implies possible diversification benefits within a given portfolio. Pro Medicus returns are very sensitive to returns on the market. As the market goes up or down, Pro Medicus is expected to follow. At this point, Pro Medicus has a negative expected return of -1.07%. Please make sure to check Pro Medicus' potential upside, kurtosis, and the relationship between the maximum drawdown and skewness , to decide if Pro Medicus performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Pro Medicus has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Forward Dividend Yield 0.0051 | Payout Ratio 0.9016 | Forward Dividend Rate 0.64 | Ex Dividend Date 2026-02-26 |
1 | Pro Medicus Expands US Market with 25M BayCare Deal - MSN | 12/05/2025 |
2 | Pro Medicus Director Peter Kempen Increases Shareholding via On-Market Purchase - TipRanks | 12/29/2025 |
3 | The total return for Pro Medicus investors has risen faster than earnings growth over the last five years - simplywall.st | 01/05/2026 |
4 | Insider Buying At Pro Medicus Sparks Fresh Look At Valuation After Share Price Pullback - simplywall.st | 01/15/2026 |
5 | Pro Medicus Stock Is Going Off But Is PME Really Worth the Hype - AD HOC NEWS | 01/21/2026 |
6 | Citi Sticks to Its Buy Rating for Pro Medicus Limited - The Globe and Mail | 01/27/2026 |
7 | Goldman Sachs Reaffirms Their Buy Rating on Pro Medicus Limited - The Globe and Mail | 02/05/2026 |
8 | A Look At Pro Medicuss Valuation As AI Jitters Pressure Tech Stocks And Create A Possible Opening - simplywall.st | 02/10/2026 |
9 | Capital Investment Trends At Pro Medicus Look Strong - Yahoo Finance | 02/13/2026 |
| Begin Period Cash Flow | 60.1 M | |
| Total Cashflows From Investing Activities | -6.6 M |
Pro |
Pro Medicus Relative Risk vs. Return Landscape
If you would invest 25,304 in Pro Medicus on November 20, 2025 and sell it today you would lose (12,708) from holding Pro Medicus or give up 50.22% of portfolio value over 90 days. Pro Medicus is producing return of less than zero assuming 4.0759% volatility of returns over the 90 days investment horizon. Simply put, 36% of all stocks have less volatile historical return distribution than Pro Medicus, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Pro Medicus Target Price Odds to finish over Current Price
The tendency of Pro Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 125.96 | 90 days | 125.96 | about 99.0 |
Based on a normal probability distribution, the odds of Pro Medicus to move above the current price in 90 days from now is about 99.0 (This Pro Medicus probability density function shows the probability of Pro Stock to fall within a particular range of prices over 90 days) .
Pro Medicus Price Density |
| Price |
Predictive Modules for Pro Medicus
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pro Medicus. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Pro Medicus Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pro Medicus is not an exception. The market had few large corrections towards the Pro Medicus' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pro Medicus, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pro Medicus within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.04 | |
β | Beta against Dow Jones | 0.86 | |
σ | Overall volatility | 38.76 | |
Ir | Information ratio | -0.26 |
Pro Medicus Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pro Medicus for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pro Medicus can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pro Medicus generated a negative expected return over the last 90 days | |
| Pro Medicus has high historical volatility and very poor performance | |
| Pro Medicus is unlikely to experience financial distress in the next 2 years | |
| About 49.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Capital Investment Trends At Pro Medicus Look Strong - Yahoo Finance |
Pro Medicus Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pro Stock often depends not only on the future outlook of the current and potential Pro Medicus' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pro Medicus' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 104.6 M | |
| Cash And Short Term Investments | 209.2 M |
Pro Medicus Fundamentals Growth
Pro Stock prices reflect investors' perceptions of the future prospects and financial health of Pro Medicus, and Pro Medicus fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pro Stock performance.
| Return On Equity | 0.77 | ||||
| Return On Asset | 0.27 | ||||
| Profit Margin | 0.98 % | ||||
| Operating Margin | 0.73 % | ||||
| Current Valuation | 12.94 B | ||||
| Shares Outstanding | 104.47 M | ||||
| Price To Book | 33.83 X | ||||
| Price To Sales | 53.41 X | ||||
| Revenue | 212.91 M | ||||
| Gross Profit | 240.25 M | ||||
| EBITDA | 164.85 M | ||||
| Net Income | 115.22 M | ||||
| Cash And Equivalents | 67.05 M | ||||
| Total Debt | 2.25 M | ||||
| Book Value Per Share | 3.72 X | ||||
| Cash Flow From Operations | 111.33 M | ||||
| Earnings Per Share | 2.24 X | ||||
| Total Asset | 338.7 M | ||||
| Retained Earnings | 239.46 M | ||||
About Pro Medicus Performance
Assessing Pro Medicus' fundamental ratios provides investors with valuable insights into Pro Medicus' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Pro Medicus is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Pro Medicus is entity of Australia. It is traded as Stock on AU exchange.Things to note about Pro Medicus performance evaluation
Checking the ongoing alerts about Pro Medicus for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pro Medicus help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pro Medicus generated a negative expected return over the last 90 days | |
| Pro Medicus has high historical volatility and very poor performance | |
| Pro Medicus is unlikely to experience financial distress in the next 2 years | |
| About 49.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Capital Investment Trends At Pro Medicus Look Strong - Yahoo Finance |
- Analyzing Pro Medicus' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pro Medicus' stock is overvalued or undervalued compared to its peers.
- Examining Pro Medicus' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pro Medicus' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pro Medicus' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pro Medicus' stock. These opinions can provide insight into Pro Medicus' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Pro Stock Analysis
When running Pro Medicus' price analysis, check to measure Pro Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Medicus is operating at the current time. Most of Pro Medicus' value examination focuses on studying past and present price action to predict the probability of Pro Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Medicus' price. Additionally, you may evaluate how the addition of Pro Medicus to your portfolios can decrease your overall portfolio volatility.